Want to see SE:SPEC full AI Analyst Report?
SpectraCure AB (SPEC) Financial Statements
SpectraCure AB Financial Overview
SpectraCure AB's market cap is currently $20.68M. The company's EPS TTM is $-0.12; its P/E ratio is -0.12; SpectraCure AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 318.00K | $ 539.00K | $ 0.00 |
| Gross Profit | $ -30.14M | $ 9.77M | $ -9.22M | $ 3.58M | $ 1.39M |
| Operating Income | $ -54.35M | $ -24.48M | $ -21.35M | $ -26.98M | $ -24.42M |
| EBITDA | $ -51.81M | $ -20.42M | $ -18.81M | $ -22.27M | $ -20.43M |
| Net Income | $ -56.08M | $ -23.00M | $ -20.44M | $ -25.33M | $ -23.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 13.53M | $ 18.27M | $ 56.95M | $ 93.18M | $ 129.69M |
| Total Assets | $ 104.47M | $ 121.00M | $ 144.83M | $ 162.42M | $ 190.52M |
| Total Debt | $ 3.01M | $ 5.14M | $ 6.72M | $ 2.70M | $ 4.90M |
| Net Debt | $ -10.52M | $ -13.13M | $ -50.23M | $ -90.48M | $ -124.79M |
| Total Liabilities | $ 10.92M | $ 14.15M | $ 14.97M | $ 12.12M | $ 14.84M |
| Stockholders' Equity | $ 93.55M | $ 106.86M | $ 129.86M | $ 150.30M | $ 175.68M |
| Cash Flow | |||||
| Free Cash Flow | $ -43.67M | $ -37.10M | $ -34.45M | $ -33.08M | $ -27.09M |
| Operating Cash Flow | $ -24.03M | $ -21.83M | $ -18.68M | $ -22.96M | $ -18.60M |
| Investing Cash Flow | $ -19.64M | $ -15.28M | $ -15.56M | $ -11.35M | $ -8.49M |
| Financing Cash Flow | $ 38.92M | $ -1.57M | $ -1.99M | $ -2.20M | $ -453.00K |
Currency in SEK
